Small cell - PDFSEARCH.IO - Document Search Engine

Small cell
Results: 941

#	Item
361	1250 Consultation Decision Analytic Protocol (DAP) to guide the assessment of diagnostic testing for Anaplastic Lymphoma Kinase (ALK) gene rearrangement in patients with advanced non-small cell lung cancer to determine e Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:14 Lung cancer Organofluorides Organochlorides Pfizer Quinazolines Crizotinib Non-small-cell lung carcinoma Anaplastic lymphoma kinase Protein kinase inhibitor Medicine Chemistry Oncology
362	Public Summary Document Application No. 1173 – Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for erlotinib treatment as a first line therapy in patients with locally advanced or metastat Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:40 Amines Quinazolines Lung cancer Organofluorides Alkynes Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Medicine Organic chemistry
363	Public Summary Document Application No. 1173 – Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for a Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:40 Quinazolines Amines Organofluorides Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
364	Public Summary Document Application No. 1161 – Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC) Sponsor/Applicant/s: Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:56 Quinazolines Amines Organofluorides Organochlorides Lung cancer Gefitinib Epidermal growth factor receptor Erlotinib Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
365	MSAC Application 1173: Consultation Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) testing for eligibility for erlotinib treatment as a first line therapy in patients Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:43 Lung cancer Amines Quinazolines Organofluorides Alkynes Gefitinib Erlotinib Non-small-cell lung carcinoma Epidermal growth factor receptor Medicine Chemistry Oncology
366	Public Summary Document Application No. 1161 – Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC) Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:55 Quinazolines Organofluorides Amines Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine
367	Public Summary Document Application No. 1173 – Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for erlotinib treatment as a first line therapy in patients with locally advanced or metastat Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:43 Amines Quinazolines Lung cancer Organofluorides Alkynes Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Medicine Organic chemistry
368	MSAC Application 1161: Final Decision Analytic Protocol (DAP) to guide the assessment of testing for mutations in the epidermal growth factor receptor (EGFR) gene in patients with locally advanced or metastatic non small Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:56 Amines Quinazolines Lung cancer Organofluorides Gefitinib Morpholines Epidermal growth factor receptor Erlotinib Non-small-cell lung carcinoma Chemistry Medicine Organic chemistry
369	Medical Services Advisory Committee Public Summary Document Reference No. 41 – Epidermal Growth Factor Receptor Gene Testing and Access to PBS listed Gefitinib Sponsors: Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2013-11-01 01:30:18 Amines Quinazolines Tyrosine kinase receptors Lung cancer Organofluorides Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Biology
370	Public Summary Document Application No. 1293 – Epidermal Growth Factor Receptor (EGFR) testing to determine eligibility for afatinib treatment in patients with locally advanced or metastatic non-small-cell lung cancer Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:26 Quinazolines Organofluorides Amines Organochlorides Lung cancer Gefitinib Erlotinib Epidermal growth factor receptor Non-small-cell lung carcinoma Chemistry Organic chemistry Medicine

UPDATE